Lupin launches Potassium Chloride Oral Solution in US Markets
Lupin has launched Potassium Chloride Oral Solution USP, 20 mEq/15mL (10 per cent) and 40 mEq/15 mL (20 per cent) in the US markets. The […]
Month: October 2018
Zydus Cadila receives USFDA approval for Exemestane tablet
Zydus Cadila has received final USFDA approval to market Exemestane tablets, used for treatment of breast cancer. The drug in the strength of 25 mg […]